Risk factor
Very poor trading liquidity
Profitability factor
Greatly overvalued vs peers
About
DOD Biotech Public Company Limited, a Thai-based enterprise, specializes in the production of dietary supplements, cosmetic goods, and various skincare solutions. Its comprehensive product lineup features skincare formulations targeting concerns such as skin clarification, anti-aging, hydration, acne management, and the reduction of dark spots. The company also offers body-shaping supplements designed to boost metabolism, inhibit carbohydrate and fat absorption, and act as appetite suppressants. Furthermore, DOD Biotech produces a range of healthcare items addressing diverse needs, including cognitive function, bone and joint health, excretory system support, sleep enhancement, immune system strengthening, vitamin supplementation, and blood sugar regulation. Their portfolio extends to products promoting visual, hair, and cardiovascular well-being. For fitness and muscle development, they supply a variety of protein products, encompassing whey and plant-based options, power gels, and energy drinks. Tailored wellness products are also available for both men and women. Beyond manufacturing, the firm provides advisory services. Established in 2011, DOD Biotech's headquarters are situated in Mueang Samut Sakhon, Thailand.
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, overvalued